Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Pasithea Therapeutics Corp. | Director | Common Stock | 1.33M | $572K | $0.43 | Jun 2, 2023 | Direct |
BioAtla, Inc. | Director | Common Stock | 55K | $83K | $1.51 | Jun 13, 2024 | Direct |
180 Life Sciences Corp. | Director | Common Stock | 48.1K | $9.05K | $0.19 | Sep 4, 2023 | Direct |
BioAtla, Inc. | Director | Stock Option (Right to Buy) | 50K | Jun 14, 2023 | Direct | ||
180 Life Sciences Corp. | Director | Non-Qualified Stock Option (right to buy) | 15K | Sep 4, 2023 | Direct | ||
Pasithea Therapeutics Corp. | Director | Stock Option (right to buy) | 7.5K | Mar 1, 2024 | Direct |